Holly Nance Group Offers Quick Cash Home Buying Solutions in Hamilton Township, NJ

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NANO Nuclear Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities...

Sineng Electric Expands U.S. Operations with New Service Center in Texas

Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia

Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated...

Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024

Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO...

Inside Flagright: Our Approach to Hiring and Team Growth

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical...

RYBREVANT® (amivantamab-vmjw) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously...

Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement...

Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed...

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients...

Valentine Roofing Named Finalist for 2024 BBB Torch Award for Ethics

Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer

United States of KAILASA Host Transformative Session at the 79th UN General Assembly Science Summit

Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple...

Regenerative Orthopedics & Sports Medicine Relocates Columbia, MD Office to New, Expanded Facility

Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024

Dr. Q - America's Best Dentist Marks 1st Anniversary with Free Dental Care Event